ArticleMedizinische Klinik, Intensivmedizin und Notfallmedizin2026
[Modern therapy of pulmonary embolism with PERT and EKOS: an advantage also for in-hospital time?]
Article in Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesToday, patients with intermediate high-risk pulmonary embolism are usually treated by a pulmonary embolism response team (PERT) and often EKOS lysis. We investigated whether this approach leads to a reduction in the hospital stay duration. MATERIALS AND
methodsA retrospective analysis of patients with intermediate high-risk pulmonary embolism clinically assessed by PERT and treated with EKOS lysis in a medical intensive care unit (ICU) between 01 October 2021 and 21 August 2024 was undertaken. The control group comprised patients suffering from intermediate high-risk pulmonary embolism, treated with medication alone (without assessment by PERT) in the ICU between 01 January 2010 and 31 December 2021. The economic/process-associated endpoint of the study was duration of hospital stay (days in hospital).
resultsA total of 45 patients were treated in the EKOS and PERT group and 31 in the control group. No differences regarding sex, vital signs, and laboratory parameters were observed. Despite the higher age of patients in the group treated by PERT and EKOS (64.7 years [53.4-71.6] vs. 54.0 years [38.6-63.1], *p = 0.03), the duration of hospital stay was significantly shorter (7.8 days [5.2-13.2] vs. 12.9 days [7.1-22.1], *p = 0.003). Time in the ICU was also significantly shorter (0.9 days for PERT and EKOS [0.5-1.5] vs. 2.0 days [0.9-6.2], *p = 0.01).
conclusionIn addition to being advantageous in situations where there is a shortage of acute care beds, a reduction of hospital stay may also potentially reduce treatment costs. This is especially important in ageing societies like Germany suffering from constantly increasing healthcare costs.
Indexed as
Identifiers
42390528What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.